DJ Abbott Laboratories Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slid 1.88% to $110.36 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.33% to 7,686.14 and Dow Jones Industrial Average falling 0.70% to 53,185.90.
Abbott Laboratories closed 19.73% below its 52-week high of $137.49, which the company reached on September 22nd.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.82% to $265.85, Pfizer Inc. $(PFE)$ rose 1.79% to $28.46, and Merck & Co. Inc. (MRK) fell 0.40% to $147.76.
Trading volume (10.5 M) remained 746,173 below its 50-day average volume of 11.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 31, 2026.